184 related articles for article (PubMed ID: 37925948)
1. Dust mite component Analysis: Identifying key allergens components for effective immunotherapy in allergic rhinitis.
Huang J; Xiang R; Tan L; Deng Y; Tao Z; Zhang W; Xu Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111111. PubMed ID: 37925948
[TBL] [Abstract][Full Text] [Related]
2. The effect of immunotherapy on cross-reactivity between house dust mite and other allergens in house dust mite -sensitized patients with allergic rhinitis.
Zhao L; Zhang Y; Zhang S; Zhang L; Lan F
Expert Rev Clin Immunol; 2021 Sep; 17(9):969-975. PubMed ID: 34388949
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy comparison and safety analysis of subcutaneous specific immunotherapy with standardized house dust mite allergen in patients with single and multiple allergic rhinitis].
Huang HH; Xu C; Liu L; Chai RN
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):774-783. PubMed ID: 35785859
[No Abstract] [Full Text] [Related]
4. Correlation between sensitization to house dust mite major allergens, age, and symptoms in Japanese house dust mite allergic subjects.
Hasegawa A; Utsumi D; Lund K; Okano M; Ohashi-Doi K; Okubo K
Int Immunopharmacol; 2022 Jun; 107():108640. PubMed ID: 35217338
[TBL] [Abstract][Full Text] [Related]
5. Serological analysis of allergic components of house dust mite provides more insight in epidemiological characteristics and clinical symptom development in North China.
Liu Y; Zhao L; Wang J; Guo Y; Wang Y; Zhang L; Wu Z; Zhu M; Yang X; Xu P; Wu S; Gao Z; Sun JL
Front Immunol; 2023; 14():1083755. PubMed ID: 37180108
[TBL] [Abstract][Full Text] [Related]
6. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
Front Immunol; 2021; 12():786738. PubMed ID: 35197963
[TBL] [Abstract][Full Text] [Related]
7. Suppression function against environmental dust exposure after Dermatophagoides pteronyssinus immunotherapy is associated with production of specific and cross-reactive immunoglobulin G4.
Feng M; Luo T; Xian M; Shi X; Qin R; Zeng X; Su Q; Li J
Clin Exp Allergy; 2022 Jul; 52(7):878-887. PubMed ID: 34962673
[TBL] [Abstract][Full Text] [Related]
8. [Profiles of IgE sensitization to dust mite allergen components in patients with allergic rhinitis and asthma].
Wang X; Pu X; Chen L; Guo M; Zheng C; Wang H; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Aug; 36(8):576-581. PubMed ID: 35959573
[No Abstract] [Full Text] [Related]
9. Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling.
Xie S; Fan R; Tang Q; Cai X; Zhang H; Wang F; Xie S; Gao K; Zhang J; Xie Z; Jiang W
Front Immunol; 2021; 12():805404. PubMed ID: 35095890
[TBL] [Abstract][Full Text] [Related]
10. Molecular Profile Sensitization to House Dust Mites as an Important Aspect for Predicting the Efficiency of Allergen Immunotherapy.
Rodinkova VV; Yuriev SD; Kryvopustova MV; Mokin VB; Kryzhanovskyi YM; Kurchenko AI
Front Immunol; 2022; 13():848616. PubMed ID: 35392080
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of subcutaneous house dust mite immunotherapy in patients with moderate to severe allergic rhinitis.
Valero A; Ibáñez-Echevarría E; Vidal C; Raducan I; Castelló Carrascosa JV; Sánchez-López J
Immunotherapy; 2022 Jun; 14(9):683-694. PubMed ID: 35465692
[TBL] [Abstract][Full Text] [Related]
12. The relationship of
Hu H; Dai J; Zheng X; Wu J; Wu L; Luo W; Sun B
Allergy Asthma Proc; 2023 Mar; 44(2):100-105. PubMed ID: 36872447
[No Abstract] [Full Text] [Related]
13. [Analysis of specific sIgE detection of house dust mites and aspergillus fumigatus in 2 535 patients with respiratory allergic diseases and respiratory infectious diseases in the Guangzhou area].
Lin YL; Wu LT; Huang HM; Liang XQ; Sun BQ; Luo WT
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Jun; 56(6):755-762. PubMed ID: 35785857
[No Abstract] [Full Text] [Related]
14. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model.
Hesse L; van Ieperen N; Habraken C; Petersen AH; Korn S; Smilda T; Goedewaagen B; Ruiters MH; van der Graaf AC; Nawijn MC
Allergy; 2018 Apr; 73(4):862-874. PubMed ID: 29318623
[TBL] [Abstract][Full Text] [Related]
16. Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study.
Hamada M; Saeki K; Tanaka I
Allergol Int; 2023 Oct; 72(4):573-579. PubMed ID: 36918306
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of exposure and sensitization to house dust mites among rhinitis patients in the steppe environment of Inner Mongolia].
Wang YL; Zhao X; Li FH; Lu Y; Tao QL; Lu MP; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 47(1):19-25. PubMed ID: 22455768
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients.
Nittner-Marszalska M; Kopeć A; Foks-Ciekalska A; Lata A; Bogacz-Piaseczyńska A; Rosiek-Biegus M; Zajac M; Bożek A
Hum Vaccin Immunother; 2022 Dec; 18(7):2148815. PubMed ID: 36444880
[TBL] [Abstract][Full Text] [Related]
19. [The correlation between the seasonal variation of house dust mite allergens exposure level in household and the level of asthma control in asthmatic children].
Xiang L; Fu Y; Wang J; Wang Q
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):177-83. PubMed ID: 24824386
[TBL] [Abstract][Full Text] [Related]
20. Molecular reactivity profiling upon immunotherapy with a 300 IR sublingual house dust mite tablet reveals marked humoral changes towards major allergens.
Potapova E; Bordas-Le Floch V; Schlederer T; Vrtala S; Huang HJ; Canonica GW; Valenta R; Matricardi PM; Mascarell L
Allergy; 2022 Oct; 77(10):3084-3095. PubMed ID: 35474582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
